Cargando…
Chronic inflammation, cancer development and immunotherapy
Chronic inflammation plays a pivotal role in cancer development. Cancer cells interact with adjacent cellular components (pro-inflammatory cells, intrinsic immune cells, stromal cells, etc.) and non-cellular components to form the inflammatory tumor microenvironment (TME). Interleukin 6 (IL-6), macr...
Autores principales: | Wen, Yalei, Zhu, Yingjie, Zhang, Caishi, Yang, Xiao, Gao, Yuchen, Li, Mei, Yang, Hongyan, Liu, Tongzheng, Tang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614255/ https://www.ncbi.nlm.nih.gov/pubmed/36313280 http://dx.doi.org/10.3389/fphar.2022.1040163 |
Ejemplares similares
-
Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic Functions
por: Guan, Tangming, et al.
Publicado: (2023) -
Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go?
por: Li, Xuefeng, et al.
Publicado: (2022) -
An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment
por: Du, Yingxi, et al.
Publicado: (2021) -
PIN1 and CDK1 cooperatively govern pVHL stability and suppressive functions
por: Chen, Jiayi, et al.
Publicado: (2023) -
The Current Application and Future Prospects of Astragalus Polysaccharide Combined With Cancer Immunotherapy: A Review
por: Kong, Fanming, et al.
Publicado: (2021)